Conference programme
ESCAIDE 2020
The full programme of ESCAIDE 2020 has now been published! Download a PDF copy below or see the full programme listed on this page.
Day 1, 24 November
Time |
Day 1 (24 November) |
|
---|---|---|
9.30-9.45 |
Introduction to ESCAIDE 2020 |
|
09.45-11.00 |
Preparation Fireside panel 1a Abstract presentations viewing |
|
11.00-11.40 |
Fireside Panel 1a (Live Q&A session) Moderated by: Ettore Severi |
|
|
Topic: Food and waterborne diseases outbreaks |
|
|
1. Outbreak of Yersinia enterocolitica in Norway, 2020, Trude M Lyngstad |
|
|
2. A Campylobacter jejuni outbreak linked to contaminated pasteurized milk in Denmark, 2020: a matched case-control study, Luís Alves de Sousa |
|
|
3. Nuts about salmonella: consumption of brazil nuts and nut bars identified as risk factor for Salmonella Typhimurium t5.6145 in case-control study, United Kingdom, May - July 2020, Ranya Mulchandani |
|
|
4. An outbreak of nalidixic acid and ciprofloxacin resistant Salmonella Enteritidis linked to eggs from Poland, Austria, 2019, Lukasz Henszel |
|
|
5. Investigation of an outbreak of ESBL- producing Salmonella Kentucky in humans linked to poultry in Malta, 2013-2020, Raquel Medialdea Carrera |
|
11.40-12.00 |
Poster mingle |
|
12.00-15.00 |
12.00-14.00 Side event: GOARN, 20 years supporting international outbreak response |
12.00-15.00 Side event: Workshop epitweetr Note: limited places available. |
15.00-16.00 |
Preparation Fireside panel 1b Abstract presentations viewing |
|
16.00-16.40 |
Fireside Panel 1b (Live Q&A session) Moderated by: Therese Westrell |
|
|
Topic: Food and waterborne diseases outbreaks (other) |
|
|
6. Epidemiological investigation of eight cases of lethal encephalitis caused by newly detected zoonotic Borna disease virus 1 in Germany, 2019-2020, Kirsten Pörtner |
|
|
7. Tracking the origin of Austrian human Brucellosis cases using whole genome sequencing, 2005-2019, Justine Schaeffer |
|
|
8. Molecular typing as a tool to investigate the national increase of cryptosporidiosis cases in Sweden autumn/winter 2019, Jessica Beser |
|
|
9. Risk assessment of foodborne Hepatitis E virus in Italy, Ornella Moro |
|
|
10. A Campylobacter outbreak warning tool in Denmark: (less) time, (more) place and person, Guido Benedetti |
|
16.40-17.00 | Interactive break | |
17.00-18.00 |
Side event: Career Compass Note: limited places available. |
Day 2, 25 November
Time |
Day 2 (25 November) |
---|---|
9.30-9.45 |
Introduction to ESCAIDE 2020 |
09.45-11.00 |
Preparation Fireside panel 2a Abstract presentations viewing |
11.00-11.30 |
Fireside panel 2a (Live Q&A session) Moderated by: Erika Duffell |
|
Topic: HIV, sexually transmitted infections and blood infections |
|
11. CD4/CD8-ratio trajectories in ClinSurv, a large multicentre HIV-cohort study from Germany 1999-2018, Kirsten Pörtner |
|
12. Low vaccination coverage for Human papillomavirus disease among men who have sex with men in France, 2019, Giuseppina Ortu |
|
13. An Evaluation of Gram-negative Bloodstream Infections Surveillance across Hospital Trusts in East of England, 2019, Nastassya Lakshmi Chandra |
|
14. Evaluation of the National Surveillance System for Notifiable Sexually Transmitted Infections, Portugal, 2015-2018, Héloïse Lucaccioni |
11.30-12.00 |
Poster mingle |
12.00-14.00 |
Side event: MediPIET |
14.00-15.00 |
Preparation Fireside panel 2b Abstract presentations viewing |
15.00-15.30 |
Fireside panel 2b (Live Q&A session) Moderated by: Kari Johansen |
|
Topic: Vaccine-preventable diseases |
|
15. Brand-specific influenza vaccine effectiveness against laboratory-confirmed influenza in Europe – results from the DRIVE network 2019/20, Anke Stuurman |
|
16. Vaccine effectiveness against influenza A(H1N1)pdm09, A(H3N2) and B: Results from the 2019/20 European I-MOVE primary care multicentre study, Esther Kissling |
|
17. Healthcare provider knowledge of and barriers to pneumococcal vaccination in at risk adults: survey results in Ireland 2020, Niamh Bambury |
|
18. Universal infant vaccination against hepatitis B: is the end of risk-group HBV vaccination for MSM approaching?, Maria Xiridou |
15.30-16.30 |
Preparation Fireside panel 2c Abstract presentations viewing |
16.30-17.00 |
Fireside panel 2c (Live Q&A session) Moderated by: Angeliki Melidou |
|
Topic: Influenza and other respiratory viruses |
|
19. Excess hospitalizations associated with RSV among children under 5 years old in France from 2010 to 2018, Demont Clarisse |
|
20. Burden of hospitalization due to respiratory syncytial virus (RSV)-very severe associated lower respiratory tract infection (VS-ALRI) in the first year of life in a major urban city, Lyon, France, Jean-sebastien Casalegno |
|
21. Novel methods in the surveillance of influenza-like illness (ILI): exploration of data from the symptom assessment app Ada, Caoimhe Cawley |
|
22. Supervised learning of syndromes from emergency department data to improve syndromic surveillance of influenza-like illness in Germany, Birte Wagner |
19.00-20.30 |
Side event: EAN General Assembly Closed event |
Day 3, 26 November
Time |
Day 3 (26 November) |
---|---|
9.45-9.50 | Introduction to ESCAIDE 2020 |
9.50-10.00 |
Message from ECDC Director Andrea Ammon |
10.00-10.10 | Message from ESCAIDE Scientific Committee Chair Mike Catchpole |
10:15-11.45 |
Keynote session on COVID-19 Chaired by Mike Catchpole (ECDC) & Magdalena Rosińska (National Institute of Public Health - National Institute of Hygiene, Poland)
|
|
|
|
|
|
|
11.45-13.00 |
Preparation Fireside panel 3a Abstract presentations viewing |
13.00-13.30 |
Fireside panel 3a (Live Q&A session) Moderated by: Eeva Broberg |
|
Topic: COVID-19 Serology and prevalence |
|
23. The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A national seroprevalence study, June-July 2020, Patricia Garvey |
|
24. SARS-CoV-2 prevalence and seroprevalence among healthcare workers in Belgian hospitals: preliminary results of a prospective cohort study, Laure Mortgat |
|
25. Seroepidemiologic study to detect antibody-mediated immunity against SARS-CoV-2 among residents and healthcare workers in the city of Plovdiv, Bulgaria, weeks 21-24, 2020, Savina Stoitsova |
|
26. Seroprevalence for SARS-CoV-2 and associated factors in the Rinkeby-Kista district of Stockholm, Sweden, 22–24 June 2020, Jessica Beser |
13.30-14.10 |
Preparation Fireside panel 3b Abstract presentations viewing |
14.10-14.40 |
Fireside panel 3b (Live Q&A session) Moderated by: Tarik Derrough |
|
Topic: COVID-19 response |
|
27. Changes in behaviour of the UK population due to COVID-19, March to June 2020, Sarah Foulkes |
|
28. Community Engagement Interviews to Assess Feasibility of Shielding and Inform COVID-19 Response in IDP Camps in Nigeria, Emily Briskin |
|
29. Establishing a COVID-19 Pandemic Severity Assessment surveillance system in Ireland - preliminary findings, Lisa Domegan |
|
30. A traffic light model for infection prevention guidelines in Norwegian schools: experiences with adjusted levels of measures, COVID-19 pandemic, 2020, Tone Johansen |
14.40-15.20 |
Preparation Fireside panel 3c Abstract presentations viewing |
15.20-15.50 |
Fireside panel 3c (Live Q&A session) Moderated by: Cornelia Adlhoch |
|
Topic: COVID-19 Surveillance |
|
31. Comparison of secondary attack rates resulting from asymptomatic, presymptomatic and symptomatic cases in a COVID-19 outbreak in Freising district, Germany, February-March 2020, Jennifer Bender |
|
32. Role of returning travellers and control measures on the dynamics of COVID-19 in Bavaria, Stefanie Böhm |
|
33. The COVID-19 epidemic in Spain: Characterisation of cases and risk factors for severe outcomes, Despina Pampaka |
|
34. COVID-19: Determinants of Hospitalization, ICU admission and Death among 20,293 reported cases in Portugal, Vasco Ricoca Peixoto |
16.00-17.30 |
Plenary B: Pandemic preparedness in times of COVID-19: how have pandemic preparedness plans contributed to responding to this global public health threat? Chaired by Vicky Lefevre (ECDC) & Frode Forland (Norwegian Institute of Public Health)
|
|
|
|
|
|
|
|
|
17.30-18.00 |
Poster mingle |
18.00-18.30 |
Wrap-up session |
Day 4, 27 November
Time |
Day 4 (27 November) |
---|---|
9.30-9.45 |
Introduction to ESCAIDE 2020 |
9.45-10.15 |
Interactive break |
10:15-11.45 |
Plenary C: Magic bullet to control antimicrobial resistance (AMR): behaviour change or new technologies? Chaired by Bojana Beović (University of Ljubljana Slovenia) & Bruno Coignard (Santé publique France)
|
|
|
|
|
|
|
11.45-13.00 |
Preparation Fireside panel 4a Abstract presentations viewing |
13.00-13.30 |
Fireside panel 4a (Live Q&A session) Moderated by: Pete Kinross |
|
Topic: Antimicrobial resistance |
|
35. Comparison of phenotypic and genotypic antimicrobial susceptibility testing of VRE and ESBL isolates in Sweden, 2016-2018, Maximilian Riess |
|
36. ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae carriage among veterinary healthcare workers in the Netherlands, Anouk Meijs |
|
37. Estimating the impact of stewardship programmes on antibiotic consumption in EU. Evidence from the Eurobarometer for the years 2009-2018, Niccolò Stamboglis |
|
38. CPE OXA-48 hospital ward outbreak in Ireland 2018-2019 - investigation of transmission patterns using social network analysis and genomics, Lisa Domegan and Carina Brehony |
13.30-14.10 |
Preparation Fireside panel 4b Abstract presentations viewing |
14.10-14.40 |
Fireside panel 4b (Live Q&A session) Moderated by: Anastasia Pharris |
|
Topic: COVID-19 Field epidemiology |
|
39. Risk factors for outbreaks of COVID-19 in adult care facilities following hospital discharge: a national cohort analysis, James Adamson |
|
40. Risk factors associated with an outbreak of COVID-19 in a meat-processing plant in Germany, April 2020, Iris Finci |
|
41. Forgotten castles: What does serology tell us about the effect of the COVID-19 pandemic on care homes?, Anna Jeffery-Smith |
|
42. Control of a COVID-19 outbreak with high case fatality ratio in Tirschenreuth district, Germany, March-May 2020, Michael Brandl |
14.40-15.20 |
Preparation Fireside panel 4c |
|
Abstract presentations viewing |
15.20-15.50 |
Fireside panel 4c (Live Q&A session) Moderated by: John Kinsman |
|
Topic: Global health and Emerging diseases |
|
43. Early detection of cholera epidemics to support control in fragile states: delays and potential impacts, Ruwan Ratnayake |
|
44. Geographical distribution of human infective RNA viruses and their disappearance, Feifei Zhang |
|
45. Strengthening country capacity for improving outbreak response to arboviral disease in West Africa, Giuseppina Ortu |
|
46. Seroprevalence of Measles Antibodies in Tunisia: First findings of 2019 National Survey, Molka Osman |
16.00-17.30 |
Plenary D: Field-epidemiology in the coming decade: where we have come from and where we should be going Chaired by Frantiska Hruba (ECDC), Susan Hahné (RIVM) and Amrish Baidjoe (ICRC)
|
|
|
|
|
|
|
17.30-18.00 |
Poster mingle |
18.00-18.30 |
Wrap-up session & Closing remarks by ECDC Director, Andrea Ammon |
19.00-21.00 |
EAN virtual drinks Closed event |